Pharmas Seek Separate Fraud, Antitrust Trials In Loestrin MDL
Warner Chilcott and Watson Pharmaceuticals pressed a Rhode Island federal judge last week to split Loestrin buyers' fraud and antitrust claims into two separate trials, arguing that a jury would be...To view the full article, register now.
Already a subscriber? Click here to view full article